Sort
15,440 grants matching “organoids”
Tissue Procurement and Processing Core
$183,636Maki Nakayama · University Of Colorado Denver · P30 · FY2021 · DK
Molecular Pharmacology Shared Resource
$183,599Aiming Yu · University Of California At Davis · P30 · FY2025 · CA
Core C: Animal Modeling and Imaging
$183,558Scott Keith Lyons · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Non-destructive optical spectroscopic assay for high-throughput metabolic characterization of in vitro cell models and patient-derived organoids
$183,530Caigang Zhu · University Of Kentucky · R21 · FY2024 · EB
Repurposing Bazedoxifene for chemoprevention in pre-invasive pancreatic cancer IPMN
$183,489Christine Iok In Chio · Columbia University Health Sciences · R21 · FY2023 · CA
A Modular Niche-Based Approach to Soft Tissue Regeneration
$183,363Adam J. Katz · University Of Virginia · R21 · FY2009 · EB
Cell Culture and Engineering Core (CCEC)
$183,342Owen M Woodward · University Of Maryland Baltimore · U54 · FY2021 · DK
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
$183,261Robert Taylor Ripley · Baylor College Of Medicine · R21 · FY2023 · CA
Optical Microscopy Core
$183,260Mark A. Mc Niven · Mayo Clinic Rochester · P30 · FY2020 · DK
Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
$183,104Jason M. Held · Washington University · R21 · FY2023 · CA
Therapeutic efficacy of the CRL inhibitor MLN4924 in NF2 mutant mesothelioma
$182,854Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Spatiotemporal transcriptomics at the maternal-fetal interface in COVID placenta
$182,500Yuping Wang · Louisiana State Univ Hsc Shreveport · R21 · FY2022 · AI
Disease Modeling Core
$182,477Holger A. Russ · University Of Colorado Denver · P30 · FY2021 · DK
Core B: Bladder Cancer Models Core
$182,372Michael M. Shen · Columbia University Health Sciences · P01 · FY2019 · CA
Novel Antibody-Drug Conjugate Combination Therapy for Treating Colorectal Cancer
$182,325Kendra S. Carmon · University Of Texas Hlth Sci Ctr Houston · R21 · FY2022 · CA
The Role of the Tumor Microenvironment in Resistance to Oncogenic KRAS Inhibition in Lung Cancer
$182,325Stefanie Galban · University Of Michigan At Ann Arbor · R21 · FY2025 · CA
CANCAN-HARVARDTHCHAN
$182,233Sheng Hui · Harvard School Of Public Health · OT2 · FY2023 · CA
Developing ACC patient-derived organoids to identify therapeutic vulnerabilities
$182,071Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post Chemotherapy
$182,054Marcin Iwanicki · The Trustees Of The Stevens Institute Of Technology · R21 · FY2022 · CA
Quantitative phase imaging andcomputational specificity (Popescu)
$181,999Rohit Bhargava · University Of Illinois At Urbana-Champaign · P41 · FY2024 · EB
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$181,915Pran K Datta · University Of Alabama At Birmingham · U54 · FY2023 · CA
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$181,913Pran K Datta · University Of Alabama At Birmingham · U54 · FY2022 · CA
BIOENGINEERED SKELETAL MUSCLES
$181,770University Of California San Francisco · P60 · FY2000 · DE
Molecular Biology Core
$181,595Juanita L Merchant · University Of Michigan At Ann Arbor · P30 · FY2019 · DK
Programmable Construction of 3D in vitro Disease Models Capturing Microenvironment Heterogeneity
$181,591Fanben Meng · University Of Nebraska Lincoln · P20 · FY2022 · GM